Immatics N.V. Warrants
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMTXW and buy or sell other stocks, ETFs, and their options commission-free!About IMTXW
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes adoptive cell therapy and TCR Bispecifics.
CEOHarpreet Singh-Jasuja, PhD
CEOHarpreet Singh-Jasuja, PhD
Employees—
Employees—
HeadquartersTuebingen, Baden Wuerttemberg
HeadquartersTuebingen, Baden Wuerttemberg
Founded2020
Founded2020
Employees—
Employees—
IMTXW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume35.19K
Average volume35.19K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.45
52 Week high$3.45
52 Week low$0.0006
52 Week low$0.0006